Phospholipid autoantibodies: Time for a new immuno-assay?

Clinical and Experimental Hypertension

Volumn 24, Issue 7-8, 2002, Pages 511-516

  Caso, Valeria ^a   Panarelli, Paolo ^a   Albi, Elisabetta ^a   Viola Magni, Maria Pia ^a   Parnetti, Lucilla ^a   Gallai, Virgilio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

2 Glycoprotein 1; Anti phospholipid Syndrome; Cardiolipin; Stroke

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CONFERENCE PAPER; CORRELATION ANALYSIS; HUMAN; IMMUNOASSAY; IMMUNOPATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; STROKE;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY SPECIFICITY; AUTOANTIGENS; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; HUMANS; IMMUNOASSAY;

EID: 0036814714     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120015327     Document Type: Conference Paper

References (28)

1. Harris, E.N. Antiphospholipid syndrome. In Rheumatology, 2nd Ed.; Kippel, J.H., Ed.; Mosby: London, UK, 1998; Vol. 7, 35.
2. Petri, M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med. Clin. North Am. 1997, 81, 151-177.
3. Harris, E.N. Special report. The Second International Antiticardiolipin Standardization Workshop/The Kingston Antiphosphopholipid Antibody Study (KAPS) Group. Am. J. Clin. Pathol. 1990, 94, 476-484.
4. Harris, E.N.; Gharavi, A.E.; Boey, M.L.; Patel, B.M.; Mackworth-Young, C.G.; Loizou, S.; Hughes, G.R. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythemathosus. Lancet 1983, 2, 1211-1214.
5. Brandt, J.T.; Triplett, D.A.; Alving, B.; Scharrer, I. Criteria for the diagnosis of lupus anticoagulant. On behalf of the subcommittee on lupus anticoagulant/antiphospholipid of scientific and standardardization. committee of the ISTH. An update. Thromb. Haemost. 1995, 74, 1185-1190.
6. Khamashta, M.A.; Hughes, G.R. Antiphospholipid antibodies and antiphospholipid syndrome. Curr. Opin. Rheumatol. 1995, 7 (5), 389-394.
7. Roubey, R.A. Antiphospholipid syndrome: Antibodies and antigens. Curr. Opin. Hematol. 2000, 7 (5), 316-320.
8. Rote, N.S.; Dostal-Johnson, D.; Branch, W.D. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am. J. Obstet. Gynecol. 1990, 163, 575-584.
9. Merkel, P.A.; Chang, Y.; Pietrangeli, S.S.; Harris, E.N.; Polisson, R.P. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. J. Rheumatol. 1999, 26 (3), 591-596.
10. Horbach, D.A.; van Oort, E.; Donders, R.C.J.M.; Derkesen, R.H.; de Groot, P.G. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb. Haemost. 1996, 76 (6), 916-924.
11. Matsuura, E.; Igarashi, M.; Igarashi, Y.; Katahira, T.; Nagae, H.; Ichikawa, K.; Triplett, D.A.; Koike, T. Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta2-glycoprotein I structure recognized by anticardiolipin antibodies. Lupus 1995, 4, 13-17.
12. El-Kadi, H.S.; Keil, L.B.; DeBari, V.A. Analytical and Clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies. J. Rheumatol. 1995, 22, 2233-2237.
13. Montalban, J.; Rio, J.; Khamastha, M.; Davalos, A.; Codina, M.; Swana, G.T.; Calcagnotto, M.E.; Sumalla, J.; Mederer, S.; Gil, A.; Hughes, G.R.; Codina, A. Value of immunologic testing in stroke patients. A prospective multicenter study. Stroke 1994, 25, 2412-2415.
14. Muir, K.W.; Squire, J.B.; Alwan, W.; Lees, K.R. Anticardiolipin antibodies in an unselected stroke population. Lancet 1994, 13 (344), 452-456.
15. Chakravarty, K.K.; Byron, M.A.; Webley, M.; Durkin, C.J.; Al-Hillawi, A.H.; Bodley, R.; Wozniak, J. Antibodies to cardiolipin in stroke: Association with mortality and functional recovery in patients without systemic lupus erythematosus. Q. J. Med. 1991, 79, 397-405.
16. Metz, L.M.; Edworthy, S.; Mydlarsky, R.; Fritzler, M.J. The Frequency of phospholipid antibodies in an unselected stroke population. Can. J. Neurol. Sci. 1998, 25, 64-69.
17. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 1997, 48, 91-94.
18. Carmelingo, M.; Casto, L.; Censori, B.; Drago, G.; Frigeni, A.; Ferraro, B.; Servalli, M.C.; Radice, E.; Mamoli, A. Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset. Acta. Neurol. Scand. 1995, 92 (1), 69-71.
19. Thurim, S.; Rand, J.H.; Wu, X-X.; Weinberger, J.; Horowitz, D.R.; Goldman, M.E.; Godbold, J.H. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 1999, 30, 1561-1565.
20. Levine, S.R.; Salowich-Palm, L.; Sawaya, K.L.; Perry, M.; Spencer, H.J.; Winkler, H.J.; Alam, Z.; Carey, J.L. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 1997, 1660-1665.
21. Ginsburg, K.S.; Liang, M.H.; Newcomer, L.; Goldhaber, S.Z.; Schur, P.H.; Hennekens, C.H.; Stampfer, M.J. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann. Intern. Med. 1992, 997-1002.
22. Ahmed, E.; Stegmayr, B.; Trifunovic, J.; Weinehall, L.; Hallmans, G.; Lefvert, A.K. Anticardiolipin antibodies are not an independent risk factor for stroke: An incident case-referent study nested within the MONICA and vasterbotten cohort project. Stroke 2000, 31, 1289-1293.
23. Sletness, K.E.; Smith, P.; Abdelnoor, M.; Arnesen, H.; Wisloff, F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet. 1992, 339, 451-453.
24. Toschi, V.; Motta, A.; Castelli, C.; Paracchini, M.L.; Zerbi, D.; Gibelli, A. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 1998, 29 (9), 1759-1764.
25. Toschi, V.; Motta, A.; Castelli, C.; Gibelli, S.; Cimminiello, C.; Molaro, G.L.; Gibelli, A. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis. 1993, 275-283.
26. Tuhrim, S.; Rand, J.H.; Wu, X.; Horowitz, D.R.; Weinberger, J.; Goldman, M.E.; Goldbold, J.H. Antiphosphatidyl serine antibodies are independently associated with ischemic stroke. Neurology 1999, 53, 1523-1527.
27. Tanne, D.; Triplett, A.D.; Levine, S.L. Antiphospholipid-protein antibodies and ischemic stroke. Not just cardiolipin any more. Stroke 1998, 29, 1755-1758.
28. Cabral, A.R.; Amigo, M.C.; Cabiedes, C.; Alarcon-Seovia, D. The antipho-spholipid/cofactor syndromes: A primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Am. J. Med. 1996, 101, 472-481.